Press-release for stocks

Prices are updated after-hours

crawled date : 2021 - 11 - 11 crawled time : 14:00

save search

Sol-Gel Technologies Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Developments
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -28.83% | O: -1.14% H: 4.7% C: 3.76%
SLGL | $0.9001 4.8% 12K

Health Technology

| -90.27% | O: 0.0% H: 1.73% C: -1.84%
financial results results

Amicus Therapeutics to Present at the Stifel 2021 Virtual Healthcare Conference
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
FOLD F | $10.62 2.81% 2.73% 2.5M

Health Technology

| -10.02% | O: 0.09% H: 3.13% C: 1.65%
conference

Celldex to Participate in Upcoming Investor Conferences
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
CLDX | $37.98 -1.43% -1.45% 590K

Health Technology

| -14.82% | O: 0.33% H: 1.13% C: -3.18%
conference

Harmony Biosciences To Participate In Two Investor Conferences In November
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
HRMY | $29.42 1.34% 1.33% 390K

Health Technology

| -31.49% | O: 0.82% H: 1.63% C: -1.02%
conference bioscience

Sio Gene Therapies Announces Successful Manufacture of Three GMP Batches of AXO-Lenti-PD Gene Therapy for Parkinson’s Disease
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
SIOX | $0.478 -20.5% 40K

Health Technology

| -75.65% | O: 2.07% H: 2.54% C: 2.03%
disease gene therapies gene therapy therapy parkinson

Nabriva Announces Availability of XENLETA® (lefamulin) in a 10-Count Oral Pack10-count oral pack – or ‘X’ pack allows for improved access and the opportunity to further expand retail availability
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
NBRV | $1.42 1.39% 720K

Health Technology

| 17.84% | O: -4.56% H: 0.81% C: -2.61%
lefamulin

IN8bio to Present Preclinical Data on the Potential for Gamma-Delta T-cell Therapy Combinations with PARP and Checkpoint Inhibitors in Solid Tumors
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
INAB | $1.0 -4.76% -5.0% 280K

| -88.3% | O: -3.04% H: 7.24% C: -1.81%
solid tumors potential therapy t-cell preclinical pre-clinical

Selecta Biosciences to Participate in Jefferies Virtual London Healthcare Conference
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
SELB 4 | $0.8812 -8.0% 2.12% 0

Health Technology

| -76.06% | O: 1.61% H: 0.0% C: -2.12%
conference bioscience

Concert Pharmaceuticals to Participate in Fireside Chat at Jefferies London Healthcare Conferences
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
CNCE | $8.37 0.36% 0

Health Technology

| 98.58% | O: -2.84% H: 2.68% C: -2.8%
conference

Kintara Therapeutics to Present at the Q4 Investor Summit Virtual Conference on November 17, 2021
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
KTRA | $0.1204 12.95% 11.46% 7.1M

Distribution Services

| -88.83% | O: 0.55% H: 5.54% C: 0.13%
q4 conference

Thank You, Veterans
Published: 2021-11-11 (Crawled : 14:00) - extremenetworks.com
EXTR 4 | $10.965 0.23% 0.23% 1.6M

Electronic Technology

| -1.94% | O: -0.26% H: 0.0% C: 0.0%

CymaBay Therapeutics to Host Post-AASLD Key Opinion Leader Webinar on Seladelpar for Primary Biliary CholangitisWebinar on Monday, November 15th, @ 4:30pm EST
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
CBAY | $32.48 0.03% 8.4M

Health Technology

| 658.64% | O: 3.21% H: 3.79% C: -2.21%

Baudax Bio Announces Clinical Program Update for Neuromuscular Blocking Agents BX-1000, BX-2000 and BX-3000
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
BXRX | $0.1864 -54.35% 330K

Health Technology

| -64.13% | O: 3.48% H: 0.22% C: -5.73%

Black Knight Honored With 2021 HIRE Vets Medallion Award for Successfully Recruiting and Employing U.S. Veterans
Published: 2021-11-11 (Crawled : 14:00) - blackknightinc.com
BKI | $75.76 0.0% 0

Technology Services

| -4.11% | O: 0.25% H: 1.31% C: -1.53%

Aptevo Therapeutics Announces Preclinical Data for Bispecific Antibody APVO603 at the Society for Immunology in Cancer Annual Meeting
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
APVO | $0.721 -6.36% -6.8% 230K

Health Technology

| -94.0% | O: 1.33% H: 0.0% C: 0.0%
cancer antibody immunology preclinical pre-clinical

Rockwell Medical Submits Investigational New Drug Application with FDA for its Proposed Clinical Trial of FPC as a Treatment for Iron Deficiency Anemia in Patients Receiving Home Infusion
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
RMTI | $1.46 -1.35% -1.37% 82K

Health Technology

| 180.83% | O: -0.87% H: 3.18% C: 2.79%
new drug treatment fda application iron deficiency anemia drug trial

Charles River Laboratories Promotes Birgit Girshick to Chief Operating Officer
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
CRL | $226.78 -0.34% 0.0% 410K

Commercial Services

| -40.06% | O: 0.68% H: 0.63% C: -0.05%

Better Therapeutics Appoints Major General Elder Granger, M.D., U.S. Army (retired) to its Board of Directors
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
BTTX | $0.009 -65.02% 180K

| -99.9% | O: -0.39% H: 1.09% C: -1.58%
CI | $352.39 1.04% 0.0% 1.3M

Health Services

| 59.22% | O: -0.18% H: 1.03% C: 0.11%
DLHC | $11.26 1.99% 1.95% 32K

Commercial Services

| -31.3% | O: -0.48% H: 0.79% C: -2.06%
CERN | $94.92 0.03%

Technology Services

| 27.65% | O: -0.32% H: 0.89% C: 0.69%

Verastem Oncology to Present at the Jefferies London Healthcare Conference
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
VSTM | $9.86 -3.62% -3.75% 150K

Health Technology

| 286.04% | O: 0.75% H: 10.11% C: 9.74%
conference